ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs ...

Innovative targeted oncology company built on next-generation ADCs and a novel discovery engine Connect with the Company on ...

In this video, Xiuning Le, MD, PhD, discusses the state of the pipeline for developing EGFR-mutated lung cancer treatments.

根据公开资料统计，2024年全年获得FDA突破性疗法认定的新药中，至少有6款由中国公司研发（不完全统计，且不包括仅引进中国开发权益的产品），其中4款用于治疗癌症。 突破性疗法认定（breakthrough therapy ...